Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Bioptimus raises $41M to develop a 'GPT for biology' | TechCrunch

Jan 14, 2025 - techcrunch.com
Bioptimus, a French AI startup, has raised $41 million to develop a foundational AI model for biology, aiming to simulate biological processes to predict disease outcomes and enhance treatment development. Co-founded by Jean-Philippe Vert, who is also the chief R&D officer at Owkin, Bioptimus leverages multimodal patient data from Owkin to train its models. The startup launched H-Optimus-0, an open-source foundation model for pathology, and plans to expand its AI platform with diverse data sources and partnerships in the pharmaceutical and biotech sectors. The latest funding round was led by Cathay Innovation, with contributions from several other investors.

France has become a hub for AI startups, with significant funding rounds for companies like Mistral AI, H, and Hugging Face. Bioptimus, founded less than a year ago, has quickly raised a total of $76 million, reflecting the current AI hype and the strong backgrounds of its co-founders. The company is preparing to release a new multi-modal foundation model later this year, which will cover a wide range of biological areas and drive advancements in medical, biotech, and cosmetic sectors. This model aims to unlock new possibilities across various industries, promoting biological discoveries.

Key takeaways:

  • Bioptimus, a French AI startup, has raised $41 million to develop a foundational AI model for biology, aiming to simulate biological processes and predict disease outcomes.
  • France is becoming a hub for AI startups, with significant funding rounds for companies like Mistral AI, H, and Hugging Face, highlighting the country's growing influence in the AI sector.
  • Bioptimus was founded by experienced professionals, including Jean-Philippe Vert and Rodolphe Jenatton, and leverages multimodal patient data from Owkin to train its foundational model.
  • The company plans to expand its AI platform with diverse data sources and partnerships, aiming to release a new multi-modal foundation model that can impact various industries, including medical, biotech, and cosmetic sectors.
View Full Article

Comments (0)

Be the first to comment!